Provider Review · Updated March 2026
MEDVi Review 2026: The Tirzepatide Specialist Worth Knowing About
MEDVi has built its entire business around compounded tirzepatide, making it the most focused option for people who specifically want that molecule. They partner with Belmar Pharmacy (a 503B facility with FDA-level quality controls), offer both injectable and oral tablet forms, and claim over 100,000 patients served. But the first-month pricing is a loss leader, regulatory risks are real, and the reviews are polarized.
Quick Facts
| Detail | MEDVi |
|---|---|
| Tirzepatide Injection | $279 first month, then $399-$499/mo |
| Tirzepatide Tablet | $279-$349 first month, then $399/mo |
| Semaglutide Injection | $179 first month, then $299/mo |
| Semaglutide Tablet | $249 first month, then $349/mo |
| What’s Included | Medication, consultations, dosing plan, labs (when required), free shipping |
| States Served | 49 states (all except North Dakota) |
| Insurance | Not accepted (HSA/FSA eligible) |
| Pharmacy Partner | Belmar Pharmacy (503B facility) |
| ClearScore | 76/100 |
What Is MEDVi?
MEDVi is a telehealth platform that focuses exclusively on metabolic health and weight management. Unlike generalist platforms like Hims (which also sells hair loss and ED products) or Ro (which covers men’s health, women’s health, and skincare), MEDVi does one thing: GLP-1 prescribing and management.
Their standout feature is compounded tirzepatide. While many competitors only offer compounded semaglutide, MEDVi built their reputation around the tirzepatide molecule (the same active ingredient in Mounjaro and Zepbound). They were one of the first platforms to offer it in both injectable and oral tablet form.
MEDVi works through the OpenLoop Health clinical network (licensed providers in 49 states) and partners with Belmar Pharmacy, an FDA-registered 503B outsourcing facility. The 503B designation means Belmar follows current Good Manufacturing Practice (cGMP) standards similar to major drug manufacturers and is subject to FDA inspection.
Pricing: Watch the Jump After Month 1
MEDVi’s first-month pricing is competitive. The ongoing pricing is higher. This is the most important thing to understand before signing up.
Compounded Tirzepatide
| Period | Injectable | Tablet |
|---|---|---|
| First month | $279 | $279-$349 |
| Ongoing | $399-$499/mo | $399/mo |
Compounded Semaglutide
| Period | Injectable | Tablet |
|---|---|---|
| First month | $179 | $249 |
| Ongoing | $299/mo | $349/mo |
What the Price Includes
Everything is bundled: medication, consultations, personalized dosing plan, metabolic report, lab work (when medically required), 24/7 provider messaging, and free temperature-controlled shipping. No separate enrollment fee, consultation fee, or membership fee.
How It Compares
| Provider | Compounded Tirzepatide | Compounded Semaglutide |
|---|---|---|
| MEDVi | $279 first month, $399-$499 ongoing | $179 first month, $299 ongoing |
| Ro | N/A (brand-name Zepbound: $299-$449 + $145 membership) | ~$199 (limited availability) |
| Hims | N/A (brand-name Zepbound: $1,899) | $199/mo |
| Found | N/A | ~$189 + $129 membership |
For compounded tirzepatide specifically, MEDVi is one of the few established options. Ro offers brand-name Zepbound but not compounded tirzepatide. Hims does not offer compounded tirzepatide at all. If you specifically want the tirzepatide molecule at a compounded price point, MEDVi is one of your primary choices.
See MEDVi's current pricing
View MEDVi Profile →How It Works
Step 1: Online Assessment (10-15 minutes)
Standard health questionnaire covering medical history, current medications, and weight-loss goals.
Step 2: Provider Review (within 24 hours)
A licensed provider through the OpenLoop Health network reviews your assessment. No mandatory consultation required, but you can request one at no extra charge.
Step 3: Lab Work (conditional)
Labs are not required upfront for everyone. MEDVi orders labs for patients with thyroid issues, diabetes, liver or kidney problems, or pancreatitis history. Standard panels include A1C, fasting glucose, lipids, liver enzymes, kidney function, and thyroid. Labs are covered by MEDVi and done at Quest Diagnostics, LabCorp, or Bioreference.
The catch: labs become mandatory after month 3. You will not get a prescription past month 4 without lab results. MEDVi also requires labs when increasing beyond Level 2 dosage. If you have recent labs (within 24 months), you can upload those instead.
Step 4: Medication Ships
Ships within 2 business days of pharmacy processing. Total time from quiz to delivery: 7 to 14 days for the first order. Refills are faster. Injectables ship with insulated containers and temperature-appropriate gel packs.
Step 5: Ongoing Treatment
Monthly follow-ups, gradual dose titration, and adjustments based on your progress and tolerance. You have 24/7 unlimited messaging access to your clinical team. For a detailed look at tirzepatide dosing schedules, see our Mounjaro dosage guide.
What I Like About MEDVi
Compounded Tirzepatide Access
This is the reason most people consider MEDVi. If you want tirzepatide (the Mounjaro/Zepbound molecule) without paying $1,000+ for brand-name, MEDVi is one of the most established options.
Why tirzepatide specifically? The SURMOUNT-5 head-to-head trial showed tirzepatide produced 20.2% weight loss versus 13.7% for semaglutide at max tolerated doses. That is 47% more weight loss, with fewer GI side effect dropouts (2.7% vs 5.6%). I am personally on Mounjaro (brand-name tirzepatide), and I understand why people seek this molecule specifically. I track my own progress with DEXA scans and body composition data to make sure I am losing fat, not muscle.
For the full clinical comparison, see our Mounjaro vs Ozempic breakdown.
Belmar Pharmacy Partnership (503B Quality)
Not all compounding pharmacies are equal. MEDVi exclusively uses Belmar Pharmacy, an FDA-registered 503B outsourcing facility. 503B facilities follow current Good Manufacturing Practice (cGMP) standards and undergo FDA inspection. MEDVi markets a “Zero-Compromise” batch validation process that includes HPLC (High-Performance Liquid Chromatography) potency testing.
This matters because Novo Nordisk’s testing of compounded GLP-1s found impurities up to 86% in some samples. Using a 503B facility with batch-level testing gives patients more confidence in medication quality. It is the strongest quality assurance claim among telehealth compounders I have reviewed.
Both Injectable and Tablet Options
MEDVi offers compounded tirzepatide in both injectable and oral tablet form. Few competitors offer the tablet option. For people who want tirzepatide without injections, this is a meaningful differentiator. The tablets do not require refrigeration (store at room temperature, 68-77 degrees F) and are easier to travel with.
All-In Pricing (No Hidden Fees)
Unlike Ro ($145 membership + medication) or Found ($129 membership + medication), MEDVi bundles everything into the medication price. No separate membership fee, no consultation fee, no shipping fee. What you see is what you pay. The first-month price jumps to ongoing pricing, but at least the ongoing price is also all-inclusive.
24/7 Provider Messaging
MEDVi includes unlimited messaging with your clinical team at any time. For dosing questions, side effect management, or titration concerns, having real-time access is valuable. Most competitors limit you to business-hours messaging with 24 to 48 hour response times.
What Could Be Better
The Price Jump After Month 1
The first month for tirzepatide injections is $279. Then it jumps to $399-$499/month. That is a 43-79% increase. Several users report being surprised by this. MEDVi discloses the pricing, but the first-month rate is prominently featured in marketing while the ongoing rate requires more digging.
Make sure you budget for the ongoing cost, not the introductory rate.
Billing and Cancellation Issues
This is MEDVi’s most common complaint across review platforms. Users report:
- Charges continuing after cancellation
- Difficulty getting refunds
- Accounts being paused instead of closed
- Unauthorized charges resuming months later
MEDVi requires 72 hours notice before your billing date to cancel. Their refund policy is strict: once medication ships for a cycle, no refund is available. The money-back guarantee (if no weight loss after 5+ months) requires documented adherence and deducts 25% for consultation costs.
Polarized Reviews
MEDVi’s Trustpilot score is 4.5 out of 5 across 4,000+ reviews, which looks strong. But their ConsumerAffairs score is approximately 2.6 out of 5, significantly lower. The positive reviews praise fast onboarding, responsive providers, and tirzepatide access. The negative reviews focus almost entirely on billing issues, shipping delays (14 days instead of the advertised “few days”), and customer service dropping off after onboarding.
MEDVi is also not BBB accredited. Take the Trustpilot score with a grain of salt and read the 1 and 2-star reviews before committing.
No Deep Coaching or Behavioral Support
MEDVi is a medication-focused platform. You get a personalized dosing plan and clinician messaging, but no 1:1 health coaching, no structured curriculum, no peer community, and no dietitian access. If you want behavioral support alongside medication, Found or Calibrate offer more.
Regulatory Risk for Compounded Tirzepatide
This is the elephant in the room. The FDA declared the tirzepatide shortage resolved in October 2024. Enforcement discretion for 503B facilities ended in March 2025, and a federal court upheld the FDA’s decision in May 2025. By September 2025, the FDA had sent warning letters to 50+ entities for GLP-1 compounding issues.
MEDVi continues operating through Belmar (503B) using patient-specific prescriptions and the “clinical difference” argument. Whether this approach survives increased FDA enforcement is uncertain. If you start on compounded tirzepatide through MEDVi, understand that the long-term availability of this product is not guaranteed.
For context on the broader regulatory situation, see our GLP-1 without insurance guide.
Who MEDVi Is Best For
MEDVi fits well if you specifically want compounded tirzepatide at a lower price than brand-name Zepbound. The typical MEDVi user is someone who:
- Has decided on tirzepatide specifically (not semaglutide) based on clinical data or prior experience
- Cannot afford brand-name Zepbound ($1,086/month list price)
- Values pharmacy quality and wants a 503B facility with batch testing
- Is comfortable with a medication-focused platform (no coaching or community needed)
- Understands and accepts the regulatory risk around compounded tirzepatide
MEDVi is not the best fit if you want semaglutide (Ro or Hims are cheaper), if you want included coaching (Found or Calibrate), if you want brand-name medications (Ro or Calibrate), or if you prioritize long-term regulatory certainty.
Compare MEDVi with other providers
Browse All Providers →MEDVi vs. the Competition
MEDVi vs. Ro
Different approaches to tirzepatide. Ro offers brand-name Zepbound at $299-$449/month plus a $145 membership (total $444-$594). MEDVi offers compounded tirzepatide at $399-$499/month all-in. The price difference narrows at higher doses. Ro includes labs, coaching, and insurance navigation that MEDVi does not match. But if you want compounded tirzepatide specifically, MEDVi is the specialist.
MEDVi vs. Hims
Hims does not offer compounded tirzepatide at all. Their brand-name Zepbound costs $1,899/month. If you want tirzepatide at an affordable price, MEDVi is the clear choice over Hims. For compounded semaglutide, Hims is cheaper ($199/mo vs MEDVi’s $299/mo ongoing).
MEDVi vs. Found
Found does not appear to list compounded tirzepatide on their medication page. They offer brand-name Zepbound and Mounjaro through insurance. For compounded tirzepatide access, MEDVi has no real competition from Found.
The Bottom Line
MEDVi does one thing well: compounded tirzepatide backed by a 503B pharmacy with batch-level testing. Their partnership with Belmar Pharmacy (503B, HPLC batch testing) offers more quality assurance than most compounding platforms. The all-in pricing is straightforward (no separate membership fees), and the 24/7 provider messaging is above average.
The caveats are real: the price jump after month 1 catches people off guard, billing complaints are frequent, and the regulatory future of compounded tirzepatide is uncertain. Budget for $399-$499/month ongoing (not the $279 first month), read the cancellation policy carefully, and understand that this product may not be available indefinitely.
For people who specifically want tirzepatide and cannot access or afford brand-name Zepbound, MEDVi is worth considering, especially if the Belmar Pharmacy partnership gives you more confidence in compounding quality than the alternatives. Compare it against other providers in our full directory or see the best GLP-1 programs for 2026 ranked.
Ready to explore MEDVi?
Check MEDVi Prices →FAQ
Is MEDVi legitimate?
MEDVi is a registered telehealth platform operating in 49 states through the OpenLoop Health clinical network. They partner with Belmar Pharmacy, an FDA-registered 503B outsourcing facility. Their Trustpilot score is 4.5/5 from 4,000+ reviews, though ConsumerAffairs rates them lower at about 2.6/5. They are not BBB accredited. The company claims to have served over 100,000 patients.
How much does MEDVi tirzepatide cost per month?
Compounded tirzepatide injections cost $279 for the first month, then $399-$499/month ongoing (the price increases as your dose increases). Tirzepatide tablets are $279-$349 for the first month, then $399/month. Compounded semaglutide is cheaper: $179 first month, then $299/month ongoing (as of March 2026).
Does MEDVi use a real compounding pharmacy?
Yes. MEDVi partners with Belmar Pharmacy, an FDA-registered 503B outsourcing facility. 503B facilities follow current Good Manufacturing Practice (cGMP) standards, are subject to FDA inspection, and perform batch-level potency testing (HPLC). This is a higher quality standard than many 503A compounding pharmacies that other telehealth platforms use.
Is compounded tirzepatide legal in 2026?
The legal status is complicated. The FDA declared the tirzepatide shortage resolved in October 2024 and ended broad compounding allowances for 503B facilities in March 2025. However, compounding may continue under Section 503A when a prescriber documents that a patient’s specific medical needs cannot be met by commercially available products. MEDVi operates in this gray area. The long-term availability of compounded tirzepatide is uncertain and depends on ongoing FDA enforcement decisions.
Can I cancel MEDVi anytime?
Yes, but you need to provide 72 hours notice before your billing date. If medication has already shipped for the current cycle, no refund is available. MEDVi offers a money-back guarantee if you do not lose weight after 5+ months, but this requires documented adherence and deducts 25% for consultation costs.
Related
Guides:
- Cheapest Way to Get GLP-1 Online (2026)
- GLP-1 Side Effects Month by Month
- How to Get Insurance to Cover GLP-1 Meds
- Compounded vs Brand-Name GLP-1
Provider Reviews:
- Ro Review · Hims Review · MEDVi Review · Found Review · Calibrate Review · SkyRx Review · Eden Review
Compare: All Providers · Best GLP-1 Programs 2026